Patent details

EP2288340 Title: NANOPARTICLE FORMULATIONS AND USES THEREOF

Basic Information

Publication number:
EP2288340
PCT Application Number:
US2009040281
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP097293161
PCT Publication Number:
WO2009126938
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
NANOPARTICLE FORMULATIONS AND USES THEREOF
French Title of Invention:
FORMULATIONS DE NANOPARTICULES ET UTILISATIONS DE CELLES-CI
German Title of Invention:
NANOTEILCHEN-FORMULIERUNGEN UND IHRE VERWENDUNGEN
SPC Number:

Dates

Filing date:
10/04/2009
Grant date:
24/06/2020
EP Publication Date:
02/03/2011
PCT Publication Date:
15/10/2009
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
24/06/2020
EP B1 Publication Date:
24/06/2020
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
10/04/2021
Expiration date:
10/04/2029
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
17/06/2020
 
 

Name:
Abraxis BioScience, LLC
Address:
86 Morris Avenue, Summit, NJ 07901, United States (US)

Inventor

1

Name:
DE, Tapas
Address:
United States (US)

2

Name:
TAO, Chunlin
Address:
United States (US)

3

Name:
DESAI, Neil, P.
Address:
United States (US)

4

Name:
TRIEU, Vuong
Address:
United States (US)

5

Name:
CI, Sherry, Xiaopei
Address:
United States (US)

Priority

1

Priority Number:
44006 P
Priority Date:
10/04/2008
Priority Country:
United States (US)

2

Priority Number:
96664 P
Priority Date:
12/09/2008
Priority Country:
United States (US)

Classification

IPC classification:
A61K 9/19; A61K 9/51; A61K 31/337;

Publication

European Patent Bulletin

1

Issue number:
202026
Publication date:
24/06/2020
Description:
Grant (B1)

2

Issue number:
202031
Publication date:
29/07/2020
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages